+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sleep Apnea Diagnostics Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4730338
  • Report
  • December 2018
  • Region: Global
  • 180 pages
  • Allied Analytics LLP
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

Sleep Apnea Diagnostics Market Overview:

The global sleep apnea diagnostics market was valued at $99 million in 2017, and is expected to reach $168 million by 2025, registering a CAGR of 6.8% from 2018 to 2025.

Sleep apnea is a sleep disorder that fluctuates with the patient’s breathing pattern. It may decrease or even stop patient’s breathing completely during sleep. In few cases, it may pause the breathing (called apnea), which can last 10 seconds or longer and can occur 30 times or more in an hour. Symptoms of sleep apnea include daytime sleepiness, loud snoring, and restless sleep. Approximately 18 million Americans suffer from sleep apnea, while only 20% have been diagnosed and treated.

The major key factors that drive the growth of the sleep apnea diagnostics market include rise in sedentary lifestyle diseases such as diabetes & others and surge in geriatric population. Obesity is considered one of the major risk factor for the development and progression of sleep apnea. In addition, technological advancements to make products more comfortable for patients and considerable upsurge in sleep apnea disorders boost the growth of the global market. However, high cost associated with these devices, limited reimbursement of these devices, and low patient awareness regarding sleep apnea are projected to hinder the market growth. Moreover, increase in preference for home healthcare devices among patients is projected to create lucrative growth opportunities in the near future.

The global sleep apnea diagnostics market is segmented based on product and region. Based on product, the market is divided into polysomnography (PSG) device, actigraphy system, respiratory polygraph, sleep apnea screening device, and oximeter. Based on end user, the market is bifurcated into hospitals & sleep laboratories and home care settings. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Sleep Apnea Diagnostics Market:

The study provides an in-depth analysis of the global sleep apnea diagnostics market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the sleep apnea diagnostics market.
Key players and their strategies are provided to understand the competitive outlook of the industry.

Sleep Apnea Diagnostics Key Market Segments:

By Product

Polysomnography Device (PSG)
Clinical PSG Device
Ambulatory PSG Device
Sleep Apnea Screening Device
Actigraphy Monitoring Device
Respiratory Polygraph
Oximeter
Finger Tip Oximeter
Handheld Oximeter
Wrist-worn Oximeter
Tabletop Oximeter
Others

By End User

Hospitals & Sleep Laboratories
Home Care Settings

By Region

North America
U.S.
Canada
Mexico

Europe
UK
France
Germany
Italy
Spain
Rest of Europe

Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific

LAMEA
Saudi Arabia
South Africa
Brazil
Rest of LAMEA

KEY MARKET PLAYERS

Cadwell Laboratories Inc.
DeVilbiss Healthcare LLC.
Koninklijke Philips N.V
Medtronic plc
Mindray
Natus Medical Incorporated
Nihon Kohden Corporation
Resmed
Smiths Medical
SomnoMedics

The other players in the value chain include (profiles not included in the report):

Cleveland Medical Devices, Inc.
Compumedics Ltd.
Fisher & Paykel Healthcare Limited
Vyaire Medical, Inc
Becton, Dickinson and Company
BMC Medical Co., Ltd

Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of obesity across the globe
3.4.1.2. Increase in number of employees working in shifts and under stressful work conditions
3.4.1.3. Technological advancements in sleep apnea diagnostic devices
3.4.2. Restraints
3.4.2.1. High cost associated with the sleep apnea diagnostic devices
3.4.2.2. Lack of awareness among patients regarding sleep apnea
3.4.3. Opportunity
3.4.3.1. Untapped markets in developing economies

CHAPTER 4: SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Polysomnography device (PSG)
4.2.1. Key trends and opportunities
4.2.2. List of Distributors
4.2.3. Market size and forecast
4.2.4. Market analysis, by country
4.2.4.1. Clinical PSG Device
4.2.4.2. Market size and forecast
4.2.4.3. Ambulators PSG Device
4.2.4.4. Market size and forecast
4.3. Sleep apnea screening device
4.3.1. Key trends and opportunities
4.3.2. List of ditributors
4.3.3. Market size and forecast
4.3.4. Market analysis, by country
4.4. Actigraphy monitoring device
4.4.1. Key trends and opportunities
4.4.2. List of distributors
4.4.3. Market size and forecast
4.4.4. Market analysis, by country
4.5. Respiratory polygraph
4.5.1. Key trends and opportunities
4.5.2. List of distributors
4.5.3. Market size and forecast
4.5.4. Market analysis, by country
4.6. Oximeter
4.6.1. Key trends and opportunities
4.6.2. List of distributors
4.6.3. Market size and forecast
4.6.4. Market analysis, by country
4.6.5. Finger Tip Oximeter
4.6.5.1. Market size and forecast
4.6.6. Handheld Oximeter
4.6.6.1. Market size and forecast
4.6.7. Wrist-worn Oximeter
4.6.7.1. Market size and forecast
4.6.8. Tabletop Oximeter
4.6.8.1. Market size and forecast

CHAPTER 5: SLEEP APNEA DIAGNOSTICS MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals & sleep laboratories
5.2.1. List of distributors
5.2.2. Market size and forecast
5.2.3. Market analysis, by country
5.3. Home care settings
5.3.1. List of distributors
5.3.2. Market size and forecast
5.3.3. Market analysis, by country

CHAPTER 6: SLEEP APNEA DIAGNOSTICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. List of distributors
6.2.3. North America market size and forecast, by country
6.2.3.1. U.S. market size and forecast, by product
6.2.3.2. U.S. market size and forecast, by end user
6.2.3.3. Canada market size and forecast, by product
6.2.3.4. Canada market size and forecast, by end user
6.2.3.5. Mexico market size and forecast, by product
6.2.3.6. Mexico market size and forecast, by end user
6.2.4. North America market size and forecast, by product
6.2.5. North America market size and forecast, by end user
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. List of distributors
6.3.3. Europe market size and forecast, by country
6.3.3.1. Germany market size and forecast, by product
6.3.3.2. Germany market size and forecast, by end user
6.3.3.3. UK market size and forecast, by product
6.3.3.4. UK market size and forecast, by end user
6.3.3.5. France market size and forecast, by product
6.3.3.6. France market size and forecast, by end user
6.3.3.7. Italy market size and forecast, by product
6.3.3.8. Italy market size and forecast, by end user
6.3.3.9. Spain market size and forecast, by product
6.3.3.10. Spain market size and forecast, by end user
6.3.3.11. Rest of Europe market size and forecast, by Product
6.3.3.12. Rest of Europe market size and forecast, by end user
6.3.4. Europe market size and forecast, by product
6.3.5. Europe market size and forecast, by end user
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. List of distributors
6.4.3. Asia-Pacific market size and forecast, by country
6.4.3.1. Japan market size and forecast, by product
6.4.3.2. Japan market size and forecast, by end user
6.4.3.3. China market size and forecast, by product
6.4.3.4. China market size and forecast, by end user
6.4.3.5. India market size and forecast, by product
6.4.3.6. India market size and forecast, by end user
6.4.3.7. Australia market size and forecast, by product
6.4.3.8. Australia market size and forecast, by end user
6.4.3.9. Rest of Asia-Pacific market size and forecast, by product
6.4.3.10. Rest of Asia-Pacific market size and forecast, by end user
6.4.4. Asia-Pacific market size and forecast, by product
6.4.5. Asia-Pacific market size and forecast, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. List of distributors
6.5.3. LAMEA market size and forecast, by country
6.5.3.1. Brazil market size and forecast, by product
6.5.3.2. Brazil market size and forecast, by end user
6.5.3.3. South Africa market size and forecast, by product
6.5.3.4. South Africa market size and forecast, by end user
6.5.3.5. Saudi Arabia market size and forecast, by product
6.5.3.6. Saudi Arabia market size and forecast, by end user
6.5.3.7. Rest of LAMEA market size and forecast, by product
6.5.3.8. Rest of LAMEA market size and forecast, by end user
6.5.4. LAMEA market size and forecast, by product
6.5.5. LAMEA market size and forecast, by end user

CHAPTER 7: COMPANY PROFILES
7.1. CADWELL INDUSTRIES INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.2. DEVILBISS HEALTHCARE
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.3. KONINKLIJKE PHILIPS N.V. (PHILIPS)
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key Strategic Moves:
7.4. MEDTRONIC PLC.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segment
7.4.4. Product portfolio
7.4.5. Business performance
7.5. MINDRAY MEDICAL INTERNATIONAL LIMITED
7.5.1. Company overview
7.5.2. Operating business segment
7.6. NATUS MEDICAL INCORPORATED
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product portfolio
7.6.4. Operating business segments
7.6.5. Business performance
7.7. NIHON KOHDEN CORPORATION
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. RESMED INC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segment
7.8.4. Product portfolio
7.8.5. Business performance
7.9. SMITHS GROUP PLC. (SMITHS MEDICAL)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key Strategic Moves:
7.10. SOMNOMEDICS GmbH
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio

List Of Tables

Table 01. Global Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 02. Sleep Apnea Diagnostics Market, For Polysomnography Device (Psg) By Region, 2017-2025 ($Million)
Table 03. Global Sleep Apnea Diagnostics Market For Sleep Apnea Screening Device, By Region, 2017-2025 ($Million)
Table 04. Sleep Apnea Diagnostics Market For Actigraphy Monitoring Device, By Region, 2017-2025 ($Million)
Table 05. Global Other Sleep Apnea Diagnostics Market For Respiratory Polygraphs, By Region, 2017-2025 ($Million)
Table 06. Global Sleep Apnea Diagnostics Market For Oximeter, By Region, 2017-2025 ($Million)
Table 07. Global Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 08. Global Sleep Apnea Diagnostics Market, For Hospitals & Sleep Laboratories, By Region 2017-2025 ($Million)
Table 09. Global Sleep Apnea Diagnostics Market, For Home Care Settings, By Region, 2017-2025 ($Million)
Table 10. Sleep Apnea Diagnostics Market, By Region, 2017-2025 ($Million)
Table 11. North America Sleep Apnea Diagnostics Market, By Country, 2017-2025 ($Million)
Table 12. U.S. Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 13. U.S. Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 14. Canada Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 15. Canada Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 16. Mexico. Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 17. Mexico Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 18. North America Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 19. North America Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 20. Europe Sleep Apnea Diagnostics Market, By Country, 2017-2025 ($Million)
Table 21. Germany Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 22. Germany Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 23. Uk Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 24. Uk Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 25. France Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 26. France Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 27. Italy Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 28. Italy Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 29. Spain Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 30. Spain Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 31. Rest Of Europe Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 32. Rest Of Europe Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 33. Europe Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 34. Europe Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 35. Asia-Pacific Sleep Apnea Diagnostics Market, By Country, 2017-2025 ($Million)
Table 36. Japan Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 37. Japan Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 38. China Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 39. China Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 40. India Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 41. India Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 42. Australia Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 43. Australia Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 44. Rest Of Asia-Pacific Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 45. Rest Of Asia-Pacific Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 46. Asia-Pacific Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 47. Asia-Pacific Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 48. Lamea Allery End User Market, By Country, 2017-2025 ($Million)
Table 49. Brazil Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 50. Brazil Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 51. South Africa Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 52. South Africa Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 53. Saudi Arabia Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 54. Saudi Arabia Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 55. Rest Of Lamea Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 56. Rest Of Lamea Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 57. Lamea Sleep Apnea Diagnostics Market, By Product, 2017-2025 ($Million)
Table 58. Lamea Sleep Apnea Diagnostics Market, By End User, 2017-2025 ($Million)
Table 59. Cadwell: Company Snapshot
Table 60. Cadwell: Operating Segments
Table 61. Cadwell: Product Portfolio
Table 62. Devilbiss: Company Snapshot
Table 63. Devilbiss: Product Portfolio
Table 64. Philips: Company Snapshot
Table 65. Philips: Operating Segments
Table 66. Philips: Product Portfolio
Table 67. Medtronic: Company Snapshot
Table 68. Medtronic: Operating Segment
Table 69. Medtronic: Product Portfolio
Table 70. Mindray: Company Snapshot
Table 71. Mindray: Operating Segments
Table 72. Natus: Company Snapshot
Table 73. Natus: Product Portfolio
Table 74. Nihon Kohden: Company Snapshot
Table 75. Nihon Kohden: Operating Segments
Table 76. Nihon: Product Portfolio
Table 77. Resmed: Company Snapshot
Table 78. Resmed: Product Portfolio
Table 79. Smiths: Company Snapshot
Table 80. Smiths: Operating Segments
Table 81. Smiths: Product Portfolio
Table 82. Somnomedics: Company Snapshot
Table 83. Somnomedics: Product Portfolio

List Of Figures

Figure 01. Sleep Apnea Diagnostic Devices Market Segmentation
Figure 02. Top Investment Pockets
Figure 03. Top Player Positioning, 2017
Figure 04. Global Sleep Apnea Diagnostics Market: Drivers, Restraints, And Opportunities
Figure 05. Comparative Share Analysis Of Sleep Apnea Diagnostics Marketfor Polysomnography Device (Psg) By Country, 2017 & 2025 (%)
Figure 06. Global Sleep Apnea Diagnostics Market For Clinical Psg Device, 2017-2025 ($Million)
Figure 07. Global Sleep Apnea Diagnostics Market For Abulators Psg Device, 2017-2025 ($Million)
Figure 08. Comparative Share Analysis Of Sleep Apnea Diagnostics Market For Sleep Apnea Screening Device, By Country, 2017 & 2025 (%)
Figure 09. Comparative Share Analysis Of Sleep Apnea Diagnostics Market For Actigraphy Monitoring Device, By Country, 2017 & 2025 (%)
Figure 10. Comparative Share Analysis Of Other Sleep Apnea Diagnostics Market For Respiratory Polygraph, By Country, 2017 & 2025 (%)
Figure 11. Comparative Share Analysis Of Sleep Apnea Diagnostics Market For Oximeter, By Country, 2017 & 2025 (%)
Figure 12. Global Sleep Apnea Diagnostics Market For Finger Tip Oximeter, 2017-2025 ($Million)
Figure 13. Global Sleep Apnea Diagnostics Market For Handheld Oximeter, 2017-2025 ($Million)
Figure 14. Market Size And Forecast Global Sleep Apnea Diagnostics Market For Wrist Worn Oximeter, 2017-2025 ($Million)
Figure 15. Market Size And Forecast Global Sleep Apnea Diagnostics Market For Table Top Oximeter, 2017-2025 ($Million)
Figure 16. Comparative Share Analysis Of Sleep Apnea Diagnostics Market, For Retail Pharmacies, By Country, 2017 & 2025 (%)
Figure 17. Comparative Share Analysis Of Sleep Apnea Diagnostics Market For Home Care Settings, By Country 2017 & 2025 (%)
Figure 18. Philips: Net Sales, 20152017 ($Million)
Figure 19. Philips: Revenue Share By Segment, 2017 (%)
Figure 20. Philips: Revenue Share By Region, 2017(%)
Figure 21. Medtronic: Net Sales, 20152017 ($Million)
Figure 22. Medtronic: Revenue Share Per Segment 2017(%)
Figure 23. Medtronic: Revenue Share By Region 2017(%)
Figure 24. Natus: Net Sales, 20152017 ($Million)
Figure 25. Natus: Revenue Share By Product, 2017 (%)
Figure 26. Natus: Revenue Share By Region, 2017 (%)
Figure 27. Nihon Kohden: Net Sales, 20152017 ($Million)
Figure 28. Nihon Kohden: Revenue Share By Segment, 2017 (%)
Figure 29. Nihon Kohden: Revenue Share By Region, 2017 (%)
Figure 30. Resmed: Net Sales, 20152017 ($Million)
Figure 31. Resmed: Revenue Share By Region, 2017 (%)
Figure 32. Smiths: Net Sales, 20152017 ($Million)
Figure 33. Smiths: Revenue Share By Division, 2017 (%)
Figure 34. Smiths: Revenue Share By Region, 2017 (%)
Note: Product cover images may vary from those shown
3 of 4
According to a new report titled, 'Sleep Apnea Diagnostics Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,' the global sleep apnea diagnostics market was valued at $99 million in 2017, and is projected to reach $168 million by 2025, growing at a CAGR of 6.8% from 2018 to 2025.

Sleep apnea is a serious sleep disorder that decreases or stops the patients breathing patterns during sleep. In some cases, this pause in breathing (called apnea) can last 10 seconds or longer and can occur 30 times or more in an hour. Symptoms of sleep apnea include daytime sleepiness, loud snoring, and restless sleep. Approximately 18 million Americans suffer from sleep apnea, while only 20% have been diagnosed and treated.

The sleep apnea diagnostics market is growing at a significant pace due to surge in incidence of sleep apnea across the globe. Further, leading manufacturers are focusing toward the technological advancements in sleep apnea devices such as Fitbit has launched a wearable smartwatch that can help in easy diagnosis of sleep apnea. However, expensive tools used for the treatment of sleep apnea, limited reimbursement of these devices, and low patient compliance are projected to hinder the market growth. Moreover, gradual increase in preference for home healthcare devices is projected to offer lucrative growth opportunities in the near future.

Based on product, the polysomnography (PSG) device generated the highest revenue in 2017 and is expected to maintain this dominance throughout the forecast period. This is attributed to the wide use of these devices in the hospitals and sleep labs, as PSG enables the doctor monitor varied parameters of sleep apnea, such as brain activity, muscle activity, breathing activity, and more to get a comprehensive interpretation of what disorder the patient is suffering from. However, the actigraphy monitoring devices segment is expected to register the highest growth rate during the forecast period, due to its increased use in the homecare settings.

Based on end user, the market is classified into hospitals & sleep laboratories and home care settings. The hospital & sleep laboratories segment dominates the global sleep apnea diagnostics market due to the preference among patients to visit hospitals for the diagnosis of sleep apnea. In addition, sleep labs possess all the different equipment and medical settings required to monitor sleep apnea.

Key Findings of the Sleep Apnea Diagnostics Market:

Based on product, the polysomnography (PSG) device segment dominated the global sleep apnea diagnostics market in 2017, and is expected to maintain this trend during the forecast period.
Actigraphy monitoring device is expected to register the highest CAGR of 7.5% from 2018 to 2025.
Based on end user, the home care settings segment is expected to register the highest CAGR of 7.2% from 2018 to 2025.
U.S. generated the highest revenue in the global sleep apnea diagnostics market in 2017, accounting for more than half of the market in North America.
Asia-Pacific was the highest contributor in the sleep apnea diagnostics market in 2017, and is anticipated to experience rapid growth during the forecast period.

North America was the leading revenue contributor to the global market in 2017, owing to increase in healthcare investments by manufacturers and surge in R&D expenditure for the development of sleep apnea diagnostics. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to increase in prevalence of sleep apnea owing to the rise in obesity, diabetes, hypertension and other diseases that increases the probability of a person to get suffer from sleep apnea.

The report provides an extensive competitive analysis and profiles of the key market players, such as Cadwell Laboratories Inc., DeVilbiss Healthcare LLC., Koninklijke Philips N.V., Medtronic plc, Mindray, Natus Medical Incorporated, Nihon Kohden Corporation, Resmed, Smiths Medical, and SomnoMedics. The other key players include Cleveland Medical Devices, Inc., Compumedics Ltd., Fisher & Paykel Healthcare Limited, Vyaire Medical, Inc., Becton, Dickinson and Company, BMC Medical Co., Ltd., and others.
Note: Product cover images may vary from those shown
4 of 4

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll